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Oxygen-dependent regulation of erythropoietin gene expression in rat
hepatocytes. The essential role of the glycoprotein hormone erythropoie-
tin (Epo) in the control of red blood cell production is well established.
Synthesis of Epo is induced in response to low oxygen (hypoxia). In
response to stimulation, increases in serum Epo levels are paralleled by
changes in the abundance of Epo mRNA. These changes indicate that the
level of Epo mRNA is the major determinant of hormone production rate
[1—3]. Studies of the organ distribution of Epo mRNA [4, 5] have
confirmed the results of organ ablation studies, which demonstrated that
in adults the kidney is the major organ responsible for the Epo production,
but the liver is capable of Epo production as well [6, 7]. More sensitive
detection methods of Epo mRNA have demonstrated small quantities in
testis, brain, lung, and spleen of rodents [3, 8].
Cellular sites of erythropoietin formation are interstitial fibro-
blasts in kidney [9], hepatocytes [2, 10] and Ito-cells [11] in liver,
and astrocytes in brain [12]. In addition, human hepatoma cell
lines (Hep 3B, Hep G2) [13] have been identified that produce
Epo in a regulated fashion in response to hypoxia [14]. This
finding enabled to study the molecular and cellular mechanisms
controling Epo expression. A series of studies that defined
different processes being involved in the oxygen signaling cascade
proposed that: (i) The oxygen sensor is a heme protein; (ii)
reactive oxygen species are involved and a heme protein catalyzes
hydrogen peroxide; (iii) hydrogen peroxide acts as an intracellular
signaling molecule; (iv) cyclic nucleotides and protein kinases and
phosphatases are involved; and (v) oxygen-inducible control ele-
ments lying in the Epo gene play an essential role and determine,
together with DNA binding proteins, the rate of transcription.
Using the Hep 3B culture system, Goldberg, Dunning and
Bunn [15] have addressed the question as to the nature of the
oxygen sensor in control of the Epo gene. Results have proposed
that the oxygen sensor is a specific heme protein that can bind
reversibly molecular oxygen [15]. Oxygen binding may result in
conformational changes which alter the activity of the putative
oxygen sensor. During hypoxia, this sensor would change from its
inactive oxy-conformation to the active deoxy-conformation, ini-
tiating the signals that lead to transcriptional activation of the Epo
gene. Changes in these conformational states can be mimicked by
various compounds, such as divalent metals, carbon monoxide or
chelating agents resulting in alteration of Epo gene expression
[13, 16]. Gorlach et al [17] have suggested that in HepG2 cells the
heme-protein is a cytochrome b. This b-cytochrome has been
proposed to catalyze hydrogen peroxide production and hydrogen
peroxide, that acts as an intracellular signaling molecule, and
controls 02-dependent Epo production [18].
Cell culture studies have provided evidence that cyclic nucleo-
tides and calcium-dependent protein kinases are involved in the
synthetic pathway of Epo [19—23].
The rapid induction of gene expression by such a physiological
stimulus as hypoxia has attracted interest in the regulation of Epo
gene expression. Control of gene expression involves complex
interactions between DNA and nuclear proteins. Cis-acting regu-
latory elements are binding sites for trans-acting nuclear factors
that determine the rate of transcription. A number of experimen-
tal approaches have been used to define important cis-acting
elements responsible for regulated expression of the Epo gene
[24—26].
A hypoxia-responsive enhancer (HRE) has been identified in
the 3' flank of the Epo gene [25]. Additional studies defined a
short sequence within this region being involved in sequence-
specific protein binding [25, 27—29].
Studies of DNA-protein interactions identified and character-
ized a factor that binds within this region [30]. This factor is
induced under hypoxia, designated the hypoxia-inducible-factor 1
(HIF-1) [30]. HIP-i [31] is a basic helix-loop-helix protein con-
sisting of two subunits. HIF-cw subunit is unique to HIP-i, whereas
HIP-p (ARNT) can dimerizc with the arylhydrocarbon receptor
and other bHLH-PAS proteins [31]. The issue of how HIF-1 itself
is regulated remains to be answered.
This report summarizes characteristics of the oxygen sensing
mechanisms in freshly isolated hepatocytes, which differ from
those in hepatoma cells.
Methods
Hepatocyte cell culture
Cells were isolated from livers from 20-day-old rats and taken in
culture as described previously [32]. HIF-a and HIP-/3 32P-labeled
riboprobes were generated by 5P6 RNA polymerase from cDNA
templates from rat hepatocytes, amplified by PCR. The length of
the protected fragments is a 313 bp fragment of HIF-cr (nt 78-391)
and a 280 bp fragment of HIP-/3 (ARNT: nt 27-307). (Accession
no. U22431 and M69238).
Measurement of mRNA by RNase protection
© 1997 by the International Society of Nephrology
RNA was extracted as described previously and was assayed by
RNase protection [32].
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Results
Response to hypoxia in primary hepatocytes
The observation that native hepatocytes isolated from rat liver
respond to low oxygen tensions with increased Epo mRNA levels
[101 permitted the study of the Epo gene expression in cells
physiologically producing the hormone in vivo. Experiments in
isolated hepatocytes exhibit oxygen-regulated modulation of Epo
mRNA levels and of Epo production [101. The time course of the
Epo mRNA levels in these primary cultures of hepatocytes is
shown in Figure 1.
The freshly isolated hepatocytes were kept at 40% °2,5% CO2
and the balance nitrogen for four hours to allow cell attachment
and reduction of the basal Epo mRNA level in the cells. After
four hours of preineubation the levels became undetectable.
Reducing the oxygen tension to 3% resulted in a marked increase
of Epo mRNA levels within 2.5 hours. Despite continued hypoxic
Mechanism of cellular signal-transduction
As a first step to identify possible signal-transduction mecha-
nisms activated by hypoxia in hepatocytes, Eckardt et al 1101
investigated if the hypoxia-induced accumulation of Epo mRNA
in hepatocytes could be mimicked by the addition of classical
second messenger molecules or agonists [10]. The data indicate
that neither cAMP, cGMP, nor adenosine increase the amount of
Epo mRNA in cells cultured under normoxia, indicating that
cAMP and cGMP-dependent kinases do not directly mediate
hypoxie signaling in these cells.
To define the role of proteinkinase C (PKC) in the oxygen-
dependent production of erythropoietin, the Epo gene expression
has been determined [32] in the presence of phorbolesters,
vasopressin (known activators of PKC), and structurally different
kinase inhibitors [32]. In summary, the data indicate that PKC
alpha is a negative modulator of Epo gene expression in hepato-
cytes by inhibiting Epo gene expression.
A kinase other than PKC, however, could be an essential
element of hypoxic signaling. Protein phosphorylation is an
important mechanism of cellular signal transduction. To examine
the possible involvement of tyrosin phosphorylation in the hypoxia
signal transduction pathway hepatocytes were treated with
genistein, which is a broad specificity inhibitor of tyrosine kinases.
In hepatocytes gcnistein has no effect on the hypoxic induction of
Epo gene expression [34], indicating that tyrosine phosphoiylation
is not required for hypoxia signal transduction.
Nature of the oxygen sensor in hepatocytes
To define the nature of the oxygen sensor in hepatocytes and to
address the question of whether a heme protein is involved, the
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Fig. 2. Oxygen-dependent changes of Epo mRNA levels in primaiy rat
hepatocytes.
18 exposure, Epo mRNA declined between five and nine hours,
before the concentration remained fairly constant. At 40% oxygen
the levels remained low and a marked difference between 40%
and 3% oxygen persisted. In Figure 2 the oxygen dependency is
given. Lowering the oxygen tension from 20% to 1% resulted in
increased Epo mRNA levels peaking at 3% 02. A series of studies
investigated the mechanisms underlying this hypoxia-mediated
process by which the expression of the Epo gene is controlled in
native hepatocytes isolated from rat livers.
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Fig. 1. Time course of eiythropoietin messenger RNA levels in isolated rat
hepatocyses. After isolation the cells were incubated for four hours at 40%
oxygen (•) and thereafter at 40% or 3% oxygen (El) for up to 18 hours.
Protected fragments were subjected to denaturing polyacryl-
amide gel electrophoresis (PAGE) and quantified by measuring
radioactivity of excised portions of the dried gel in liquid scintil-
lant.
Measurement of total RNA synthesis
[3H]-uridine incorporation into trichloroaeeticacid (TCA)-in-
solube material was used as a measure of total RNA synthesis as
described [321.
Preparation of nuclear extracts
Nuclear extracts were prepared as described previously [331.
Electrophoretic mobility shift assay (EMSA)
The gel shift assays were done as previously described [331.
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the effect of hypoxia on Epo mRNA levels in cultured hepatocytes
[10, 35]. These data suggest that in hepatocytes a heme protein of
the type found in hepatoma cells is not required for the oxygen
sensing. Finally, when hepatocytes were incubated with desferri-
oxamine, the basal level of Epo gene expression did not change.
Desferrioxamine also did not influence the effects of hypoxia on
Epo mRNA levels [33]. Inhibiting heme synthesis by Pb(Ac)2 had
no effect on hypoxia-induced Epo gene expression, suggesting that
a heme protein sensitive to metals and CO is of less importance
for the stimulation of Epo gene expression in hepatocytes [10, 351.
Role of reactive oxygen species in mediating the oxygen signal
Reactive oxygen species such as H202 may oxidize sulfhydryl
groups of regulatory proteins and inhibit signals. The addition of
hydrogen peroxide to the culture medium of hepatocytes did not
change Epo mRNA levels in cells kept at either high or low
oxygen tension. Scavengers of H2O2 such as catalase did not
influence Epo mRNA levels. Hydrogen peroxide and catalase did
not affect total RNA synthesis [331.
These observations indicate that hydrogen peroxide is not
necessarily a mediator of the oxygen signaling process controling
Epo gene expression in hepatocytes. The combination of a heme
protein proposed to catalyze H202 production and the subsequent
mediating function of hydrogen peroxide in the oxygen signaling
pathway controling Epo gene expression are not required in
hepatocytes.
Role of de novo protein synthesis in Epo gene induction
The effects of cycloheximide, an inhibitor of protein synthesis,
suggest that protein synthesis is required for induction of the Epo
gene. In the presence of cycloheximide the hypoxia-induced
stimulation was abrogated [33]. Suitable proteins for this newly
synthesized protein as mentioned above are: a protein that
functions as a oxygen sensor, proteinkinases or phosphatases, or
another kind of protein. The potential importance of specifically
synthesized DNA-binding proteins was examined by analyzing
nuclear extracts from hepatocytes in binding assays.
Fig. 3. Epo mRNA levels (A) and rates of total RNA synthesis (B) in primaiy
cultures of hepatocytes incubated at 40% oxygen or 3% oxygen in presence of
10% GO, CoCl NiCl, MnCI2, ZnCl2, desferrioxamine and Pb(Ac)
responses of the Epo gene expression to carbon monoxide, to
various divalent metals such as cobalt, zinc, nickel and manganese
[10, 35], and the action of the chelating agent desferrioxamine
were studied as summarized in Figure 3.
Exposure to carbon monoxide moderately attenuated the Epo
response to hypoxia. These effects, however, went in parallel to
similar reductions of total RNA synthesis [35]. The response of
Epo gene expression to divalent metals was tested by exposure of
cells to CoO2, NiCl2, MnCl7 and ZnC12 [10, 35]. Cobalt did not
increase Epo gene expression in hepatocytes either under high
nor low oxygen tensions; contrarily, the hypoxia-induced rise of
Epo mRNA was attenuated in the presence of cobalt in the
hepatocytes. Among the other metals only ZnCI2 elicited a strong
and dose-dependent decrease in Epo mRNA levels that was not
associated with decrease of total RNA synthesis. ZnCl2 abolished
Role of cis- and trans-acting regulatory elements determining the
rate of Epo expression
In hepatocytes electrophoretic mobility shift assays identified a
nuclear factor which specifically binds to a 18 bp sequence lying in
the enhancer region 3' of the Epo gene. In addition, an activity
has been found for a factor that binds constitutively [33]. The
DNA-binding protein, HIF-1, a hypoxia inducible factor, was
found in hypoxic and nonhypoxic nuclear extracts with higher
binding activity of HIF- 1 under hypoxic conditions. Cyclohexi-
mide treatment abolished the induction of HIF-binding, and the
constitutive binding remained unaffected. These data suggest that
protein synthesis is required for hypoxie induction of HIF-1
binding activity and that binding of HIF-1 to the hypoxia-
inducible enhancer is required for transcriptional induction of the
Epo gene under hypoxia.
HIF-1 consists of two subunits [311, HIF-a and HIF-j3, which
form a heterodimer to express full activity. Whether HIF-1 itself
is oxygen regulated was studied by investigating the mRNA levels
of HIF-cw and HIF-J3 after hypoxic induction. The hepatocytic
mRNA levels of these two subunits remain largely constant under
normoxic conditions. Likewise, reduced oxygen tensions had no
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A Fig. 4. Hepatocytic mRNA levels of (A) eiythropoietin, (B) H!F-a and (C)
HJF-13 After 2.5 hours of incubation the mRNA levels of Epo increased
under hypoxia, the mRNA levels of HIF-a and HIF-13 remained constant
under normoxic and hypoxic conditions.
70
influence on the mRNA levels of the HIF-a and HIF-/3 subunit
(Fig. 4). This suggests that HIF-1 is not regulated on the
50 transcriptional level and regulation occurs on the post-transcrip-
tional or translational level.
In summary, the oxygen sensing mechanism in primary hepa-
tocytes remains to be clarified. Hypoxia is a potent stimulus
30 resulting in a 15-fold increase of Epo gene expression.So far, no evidence has been obtained that the primary sensor
is a heme protein and that subsequent hydrogen peroxide produc-
tion is involved in mediating this signal.
Signal-transduction mechanisms involving classical second mes-
10 senger molecules appear to play no role, and only protein kinase
C-a was found to be a negative modulator of Epo gene expression.
A positively modulating kinase that influences the signaling
cascade by phosphorylation remains to be defined.
B Studies on the regulation of Epo gene transcription identified a
DNA-binding protein that binds a part of the enhancer region
100 lying 3' of the Epo gene, and this binding activity increases under
hypoxia. The regulation of this hypoxia inducible factor HIF-i
occurs on the post-transcriptional or translational level because
80 the mRNA levels of the two subunits HIF-a and HIF-f3 remained
constant after hypoxic induction.
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